141st APHA Annual Meeting

In This section

290758
Association between intestinal infections and development of irritable bowel syndrome (IBS)

Sunday, November 3, 2013

G. Reza Najem, MD, MPH, PhD , Preventive Medicine and Community Health, New Jersey Medical School, Newark, NJ
Deborah Ablordeppey, MPH , Dept Preventive Medicine and Community Health, C/A UMDNJ-New Jersey Medical School, Newark, NJ
METHODS: Systematic review of the medical literature (1999-2012) was used to find 7 case-control studies of association between intestinal infections and development of Irritable Bowel Syndrome (IBS). Meta-analysis was used to evaluate the association. 95% CI (confidence interval) was calculated for exposed and non-exposed controls. Test of heterogeneity was also performed. RESULTS: The median incidence of IBS in the cases was 8% (Range 4.0–31) and for the controls 1% (0.3 - 11). However, the lower limits of 95% CI for 3 studies were lower than 1 odd ratio (OR). One study had a wider CI is considered to be caused by small sample size. The other 4 studies show significantly greater-than-1 OR. Specifically, two have narrower CIs due to the relatively large sample sizes. For the pooled studies, the OR based on The Mantel-Haenstzel fixed effects model was 4.1 (95% CI 3.3–5.1). A random effects model was used, as the test shows with significant heterogeneity (p < 0.0001). CONCLUSIONS: This study is consistent with previous research; we found that the individuals who have Intestinal Infections are more likely to develop IBS

Learning Areas:
Epidemiology

Learning Objectives:
Evaluate the association of Irritable Bowel Syndrome with Intestinal Infection.

Keywords: Infectious Diseases, Risk Assessment

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I designed the study
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.